Skip to content
HowShorted

Phathom Pharmaceuticals, Inc. short interest in 2024

In 2024, Phathom Pharmaceuticals, Inc.'s disclosed short interest ran from 14.31% of shares outstanding on 12 Jan 2024 to 21.87% on 31 Dec 2024, a change of +7.56 percentage points. The year's high was 29.46% on 15 Oct 2024 and its low 14.31% on 12 Jan 2024, averaging 21.60% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 32.10 days on 14 Jun 2024. Full history: Phathom Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Phathom Pharmaceuticals, Inc. in 2024

2024 in figures

Start of year
14.31% (12 Jan 2024)
End of year
21.87% (31 Dec 2024)
Change
+7.56 pp
High
29.46% (15 Oct 2024)
Low
14.31% (12 Jan 2024)
Average
21.60%
Highest days to cover
32.10 (14 Jun 2024)
SEC filings marked
8

Every report in 2024

Phathom Pharmaceuticals, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202414.31%15.31
31 Jan 202415.07%13.66
15 Feb 202416.16%12.86
29 Feb 202415.15%5.22
15 Mar 202417.86%13.3310-K filed, results (8-K)
28 Mar 202418.21%12.86
15 Apr 202420.58%12.89
30 Apr 202420.17%24.82
15 May 202420.83%18.3010-Q filed, results (8-K)
31 May 202421.08%26.15
14 Jun 202422.41%32.10
28 Jun 202422.92%20.56
15 Jul 202422.37%19.63
31 Jul 202423.49%14.60
15 Aug 202423.91%22.2610-Q filed, results (8-K)
30 Aug 202425.74%15.49
13 Sep 202426.04%15.67
30 Sep 202428.90%14.14
15 Oct 202429.46%17.64
31 Oct 202429.28%18.21
15 Nov 202421.45%5.7310-Q filed, results (8-K)
29 Nov 202420.55%12.63
13 Dec 202420.67%14.82
31 Dec 202421.87%14.43

See also: Phathom Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.